In contrast to its tumor-promoting function, IGF2BP1 has also been found to inhibit malignant tumor phenotypes and correlate with better prognosis of cancer patients in breast cancer and gallbladder cancer (27). The gene discussed is IGF2BP1; the disease is breast carcinoma.